Bellerophon Therapeutics, Inc. Profile Avatar - Palmy Investing

Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery…

Biotechnology
US, Warren [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Bellerophon Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Bellerophon Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Bellerophon Therapeutics, Inc..

End of BLPH's Analysis
CIK: 1600132 CUSIP: 078771300 ISIN: US0787713009 LEI: - UEI: -
Secondary Listings
BLPH has no secondary listings inside our databases.